Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Sher

Showing results (101-110 of 159) with videos related to

Pageof 16
Sort By:
Journal of the National Cancer Institute|August 20, 2025
Impact of daily adaptive head and neck radiotherapy on toxicity and quality-of-life: results of the DARTBOARD phase II randomized trialDavid J Sher, Vladimir Avkshtol, Mu-Han Lin, et al.
Journal of Pain and Symptom Management|January 6, 2019
Risk of Unplanned Hospital Encounters in Patients Treated With Radiotherapy for Head and Neck Squamous Cell CarcinomaZachary R Moore, Nhat-Long Pham, Jennifer Lobo Shah, et al.
Oral Oncology|November 21, 2021
Prognostic impact of matted lymphadenopathy in patients with oropharyngeal squamous cell carcinoma treated with definitive chemoradiotherapyKevin Burningham, William Moore, Dominic Moon, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2024
Stereotactic Ablative Radiotherapy for T1 to T2 Glottic Larynx Cancer: Mature Results From the Phase 2 GLoTtic Larynx-SABR TrialDavid J Sher, Vladimir Avkshtol, Dominic Moon, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2023
HYPORT: Phase 1 Study of 3-Week Hypofractionated Postoperative Radiation Therapy for Head and Neck Squamous Cell CarcinomaDominic H Moon, Vladimir Avkshtol, Dat Vo, et al.
Head & Neck|December 15, 2018
Association between treatment delays and oncologic outcome in patients treated with surgery and radiotherapy for head and neck cancerVasu Tumati, Lawrence Hoang, Baran D Sumer, et al.
American Journal of Otolaryngology|August 29, 2022
Smoking and other patient factors in HPV-mediated oropharynx cancer: A retrospective cohort studyKelly Schostag, Patrick T Lynch, Taylor Leavitt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 6, 2022
Long-term opioid use in patients treated with head and neck intensity-modulated radiotherapyLucian Zhao, Dominic H Moon, Vladimir Avkshtol, et al.
Head & Neck|February 23, 2017
Cutaneous adnexal adenocarcinoma with exquisite sensitivity to trastuzumabTimothy J Brown, David J Sher, Lucien A Nedzi, et al.
Practical Radiation Oncology|July 14, 2020
The Evolution and Future of the American Society for Radiation Oncology (ASTRO) Clinical Practice Guidelines: A Report From the ASTRO Methodology Work Group on Behalf of the Guideline SubcommitteeSandra Zaky, Alvin R Cabrera, Lisa Bradfield, et al.
Pageof 16

Showing results (101-110 of 159) with videos related to

Sort By:
Pageof 16
Journal of the National Cancer Institute|August 20, 2025
Impact of daily adaptive head and neck radiotherapy on toxicity and quality-of-life: results of the DARTBOARD phase II randomized trialDavid J Sher, Vladimir Avkshtol, Mu-Han Lin, et al.
Journal of Pain and Symptom Management|January 6, 2019
Risk of Unplanned Hospital Encounters in Patients Treated With Radiotherapy for Head and Neck Squamous Cell CarcinomaZachary R Moore, Nhat-Long Pham, Jennifer Lobo Shah, et al.
Oral Oncology|November 21, 2021
Prognostic impact of matted lymphadenopathy in patients with oropharyngeal squamous cell carcinoma treated with definitive chemoradiotherapyKevin Burningham, William Moore, Dominic Moon, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2024
Stereotactic Ablative Radiotherapy for T1 to T2 Glottic Larynx Cancer: Mature Results From the Phase 2 GLoTtic Larynx-SABR TrialDavid J Sher, Vladimir Avkshtol, Dominic Moon, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2023
HYPORT: Phase 1 Study of 3-Week Hypofractionated Postoperative Radiation Therapy for Head and Neck Squamous Cell CarcinomaDominic H Moon, Vladimir Avkshtol, Dat Vo, et al.
Head & Neck|December 15, 2018
Association between treatment delays and oncologic outcome in patients treated with surgery and radiotherapy for head and neck cancerVasu Tumati, Lawrence Hoang, Baran D Sumer, et al.
American Journal of Otolaryngology|August 29, 2022
Smoking and other patient factors in HPV-mediated oropharynx cancer: A retrospective cohort studyKelly Schostag, Patrick T Lynch, Taylor Leavitt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 6, 2022
Long-term opioid use in patients treated with head and neck intensity-modulated radiotherapyLucian Zhao, Dominic H Moon, Vladimir Avkshtol, et al.
Head & Neck|February 23, 2017
Cutaneous adnexal adenocarcinoma with exquisite sensitivity to trastuzumabTimothy J Brown, David J Sher, Lucien A Nedzi, et al.
Practical Radiation Oncology|July 14, 2020
The Evolution and Future of the American Society for Radiation Oncology (ASTRO) Clinical Practice Guidelines: A Report From the ASTRO Methodology Work Group on Behalf of the Guideline SubcommitteeSandra Zaky, Alvin R Cabrera, Lisa Bradfield, et al.
Pageof 16